| 1 |
The history of the tetracyclines
Mark L. Nelson, Stuart B. Levy · Annals of the New York Academy of Sciences
|
Dec 2011 |
474 |
| 2 |
The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution.
Michael N. Alekshun, Stuart B. Levy, Tanya R. Mealy et al. · Nature Structural Biology
|
Aug 2001 |
389 |
| 3 |
Omadacycline for Community-Acquired Bacterial Pneumonia
Roman Stets, Monica Popescu, Joven Gonong et al. · New England Journal of Medicine
Open access |
6 Feb 2019 |
236 |
| 4 |
Breakthrough advances in low loss, tunable dielectric materials
L. C. Sengupta, Somnath Sengupta · Materials Research Innovations
|
Apr 1999 |
197 |
| 5 |
In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline
Ann B. Macone, B. K. Caruso, Raina G. Leahy et al. · Antimicrobial Agents and Chemotherapy
Open access |
3 Dec 2013 |
170 |
| 6 |
Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
Michael P. Draper, Shelagh Weir, Ann B. Macone et al. · Antimicrobial Agents and Chemotherapy
Open access |
17 Sep 2013 |
165 |
| 7 |
Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia
Peter Einar Pertel, Patricia Bernardo, Charles M. Fogarty et al. · Clinical Infectious Diseases
|
14 Mar 2008 |
163 |
| 8 |
Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance
Kerry L. LaPlante, Abhay Dhand, Kelly Wright et al. · Annals of Medicine
Open access |
20 Jun 2022 |
162 |
| 9 |
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
William D. O’Riordan, Sinikka Green, J. Scott Overcash et al. · New England Journal of Medicine
|
6 Feb 2019 |
157 |
| 10 |
Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
Mark H. Gotfried, Karolyn S. Horn, Lynne K. Garrity-Ryan et al. · Antimicrobial Agents and Chemotherapy
Open access |
10 Jul 2017 |
142 |
| 11 |
Silencing and Un-silencing of Tetracycline-Controlled Genes in Neurons
Peixin Zhu, Marı́a Isabel Aller, Udo Baron et al. · PLoS ONE
Open access |
19 Jun 2007 |
142 |
| 12 |
Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline
Laura Honeyman, Mohamed Ismail, Mark L. Nelson et al. · Antimicrobial Agents and Chemotherapy
Open access |
9 Sep 2015 |
135 |
| 13 |
Omadacycline: Development of a Novel Aminomethylcycline Antibiotic for Treating Drug-Resistant Bacterial Infections
Stephen A. Villano, Judith N. Steenbergen, Evan Loh · Future Microbiology
Open access |
19 Aug 2016 |
117 |
| 14 |
Brief communication: Mass spectroscopic characterization of tetracycline in the skeletal remains of an ancient population from Sudanese Nubia 350–550 CE
Mark L. Nelson, Andrew R. DiNardo, Jeffery Hochberg et al. · American Journal of Physical Anthropology
|
17 Jun 2010 |
106 |
| 15 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic
Sébastien Tanaka, Judith N. Steenbergen, Stephen A. Villano · Bioorganic & Medicinal Chemistry
Open access |
18 Jul 2016 |
104 |
| 16 |
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
William D. O’Riordan, Carrie Cardenas, Elliot Shin et al. · The Lancet Infectious Diseases
|
29 Aug 2019 |
98 |
| 17 |
Microbiology and Preclinical Review of Omadacycline
James A. Karlowsky, Judith N. Steenbergen, George G. Zhanel · Clinical Infectious Diseases
Open access |
13 May 2019 |
92 |
| 18 |
Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy
Michelle L. Hastings, Joel Berniac, Ying Hsiu Liu et al. · Science Translational Medicine
Open access |
4 Nov 2009 |
87 |
| 19 |
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
Charles Michael Gibson et al. · American Heart Journal
Open access |
13 Oct 2020 |
85 |
| 20 |
Nonlinear response and power handling capability of ferroelectric BaxSr1−xTiO3 film capacitors and tunable microwave devices
Andrey B. Kozyrev, Andrey V. Ivanov, T. B. Samoǐlova et al. · Journal of Applied Physics
|
Nov 2000 |
84 |
| 21 |
A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections
Gary J. Noel, Michael P. Draper, Howard I. Hait et al. · Antimicrobial Agents and Chemotherapy
Open access |
21 Aug 2012 |
82 |
| 22 |
Small Molecule Inhibitors of LcrF, a Yersinia pseudotuberculosis Transcription Factor, Attenuate Virulence and Limit Infection in a Murine Pneumonia Model
Lynne K. Garrity-Ryan, Oak K. Kim, Joan-Miquel Balada-Llasat et al. · Infection and Immunity
Open access |
8 Sep 2010 |
73 |
| 23 |
Commensals upon us
Michael N. Alekshun, Stuart B. Levy · Biochemical Pharmacology
|
8 Feb 2006 |
71 |
| 24 |
Strain-relieved Ba0.6Sr0.4TiO3 thin films for tunable microwave applications
Wontae Chang, S. W. Kirchoefer, J.M. Pond et al. · Journal of Applied Physics
|
28 Jul 2002 |
66 |
| 25 |
An Outbreak of Pseudomonas aeruginosa Pneumonia and Bloodstream Infection Associated With Intermittent Otitis Externa in a Healthcare Worker
Anne Zawacki, Edward J. OʼRourke, Gail Potter-Bynoe et al. · Infection Control and Hospital Epidemiology
|
Dec 2004 |
65 |
| 26 |
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
Danielle A. Nicklas, Emily C. Maggioncalda, Elizabeth Story-Roller et al. · Antimicrobial Agents and Chemotherapy
Open access |
18 Oct 2021 |
63 |
| 27 |
Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain
Richard L Rauck, Jeffrey Potts, Qinfang Xiang et al. · Postgraduate Medicine
Open access |
4 Dec 2015 |
63 |
| 28 |
N-Hydroxybenzimidazole Inhibitors of the Transcription Factor LcrF in Yersinia: Novel Antivirulence Agents
Oak K. Kim, Lynne K. Garrity-Ryan, Victoria J. Bartlett et al. · Journal of Medicinal Chemistry
Open access |
26 Aug 2009 |
62 |
| 29 |
Characterization of quality of BaxSr1−xTiO3 thin film by the commutation quality factor measured at microwaves
S. V. Razumov, Andrei V. Tumarkin, M. M. Gaĭdukov et al. · Applied Physics Letters
|
26 Aug 2002 |
61 |
| 30 |
Novel anti-infection agents: Small-molecule inhibitors of bacterial transcription factors
Todd E. Bowser, Victoria J. Bartlett, Mark C. Grier et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
22 Aug 2007 |
56 |
| 31 |
Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis
Jenni M. Vuola, Matti A. Ristola, Bernard F. Cole et al. · AIDS
|
21 Oct 2003 |
56 |
| 32 |
Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects
Haiying Sun, Lillian S. L. Ting, Surendra Machineni et al. · Antimicrobial Agents and Chemotherapy
Open access |
11 Oct 2016 |
55 |
| 33 |
Clinical disposition, metabolism andin vitrodrug–drug interaction properties of omadacycline
Jimmy Flarakos, Yancy Du, Helen Gu et al. · Xenobiotica
Open access |
8 Aug 2016 |
51 |
| 34 |
Computational methods to estimate drug development parameters.
Podlogar Bl, Ingo Muegge, Brice Lj · PubMed
|
2001 |
51 |
| 35 |
Versatile and Facile Synthesis of Diverse Semisynthetic Tetracycline Derivatives via Pd-Catalyzed Reactions
Mark L. Nelson, Mohamed Y. Ismail, Laura McIntyre et al. · The Journal of Organic Chemistry
|
21 Jun 2003 |
50 |
| 36 |
New advances in antibiotic development and discovery
Michael N. Alekshun · Expert Opinion on Investigational Drugs
|
Feb 2005 |
50 |
| 37 |
Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2
Kelley C. Larson, Michael P. Draper, Maciej A. Lipko et al. · Inflammation Research
|
30 Jun 2009 |
49 |
| 38 |
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic
Steven M. Opal, Thomas M. File, Tom van der Poll et al. · Clinical Infectious Diseases
Open access |
13 May 2019 |
48 |
| 39 |
Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function
Jolene Kay Berg, Evan L. Tzanis, Lynne K. Garrity-Ryan et al. · Antimicrobial Agents and Chemotherapy
Open access |
20 Nov 2017 |
48 |
| 40 |
Omadacycline for Acute Bacterial Skin and Skin Structure Infections
Fredrick M. Abrahamian, George Sakoulas, Evan L. Tzanis et al. · Clinical Infectious Diseases
Open access |
13 May 2019 |
46 |
| 41 |
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation
Christopher G. Bunick, Jonette E. Keri, Sébastien Tanaka et al. · Antibiotics
Open access |
15 Apr 2021 |
43 |
| 42 |
Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14 C-Omadacycline in Rats
Wen H. Lin, Jimmy Flarakos, Yancy Du et al. · Antimicrobial Agents and Chemotherapy
Open access |
8 Nov 2016 |
43 |
| 43 |
Effect of Food on the Bioavailability of Omadacycline in Healthy Participants
Evan L. Tzanis, Amy L. Manley, Stephen A. Villano et al. · The Journal of Clinical Pharmacology
Open access |
19 Aug 2016 |
43 |
| 44 |
Targeting virulence to prevent infection: to kill or not to kill?
Michael N. Alekshun, Stuart B. Levy · Drug Discovery Today Therapeutic Strategies
|
16 Nov 2004 |
42 |
| 45 |
MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis
Paul Casaz, Lynne K. Garrity-Ryan, David McKenney et al. · Microbiology
|
Dec 2006 |
40 |
| 46 |
N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability
Mark C. Grier, Lynne K. Garrity-Ryan, Victoria J. Bartlett et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
13 Apr 2010 |
38 |
| 47 |
Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens
Lu Ann Bundrant, Evan L. Tzanis, Lynne K. Garrity-Ryan et al. · Antimicrobial Agents and Chemotherapy
Open access |
27 Nov 2017 |
37 |
| 48 |
Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture
Muhammad Bakari, Robert D. Arbeit, Lillian Mtei et al. · BMC Infectious Diseases
Open access |
6 Mar 2008 |
37 |
| 49 |
Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study
J. Scott Overcash, Pouru Bhiwandi, Lynne K. Garrity-Ryan et al. · Antimicrobial Agents and Chemotherapy
Open access |
12 Mar 2019 |
36 |
| 50 |
The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome
Corina G. Heidrich, Sanya Mitova, Andreas Schedlbauer et al. · Antibiotics
Open access |
22 Sep 2016 |
34 |